Jacob William Buster Mendenhall

Jacob William Buster Mendenhall ( JACOB WILLIAM BUSTER MENDENHALL ) is Oral Oral & Maxillofacial Surgery Physician in Oklahoma City, OK. The NPI Number for Jacob William Buster Mendenhall is 1033252937.

The current location address for Jacob William Buster Mendenhall is 10900 HEFNER POINTE DR SUITE 204 Oklahoma City, OK 73120 and the contact number is 4054630004 and fax number is 4054630010. The mailing address for Jacob William Buster Mendenhall is 10900 HEFNER POINTE DR SUITE 204 Oklahoma City, OK 73120- 4054630044 (mailing address contact number - 4054630004).

Oral and maxillofacial surgeons are trained to recognize and treat a wide spectrum of diseases, injuries and defects in the head, neck, face, jaws and the hard and soft tissues of the oral and maxillofacial region. They are also trained to administer anesthesia, and provide care in an office setting. They are trained to treat problems such as the extraction of wisdom teeth, misaligned jaws, tumors and cysts of the jaw and mouth, and to perform dental implant surgery.

What is the NPI Number for Jacob William Buster Mendenhall ?

Answer: The NPI Number for Jacob William Buster Mendenhall is 1033252937

Where is Jacob William Buster Mendenhall located?

Answer: Jacob William Buster Mendenhall is located at 10900 HEFNER POINTE DR SUITE 204 Oklahoma City, OK 73120.

What is the specialty for Jacob William Buster Mendenhall ?

Answer: The Specialty of Jacob William Buster Mendenhall is Oral Oral & Maxillofacial Surgery Physician.

Are there any online reviews for Jacob William Buster Mendenhall ?

Answer: Yes! Check It Now.

Are there any other health care providers in Oklahoma City, OK?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Oral Surgery (Dentist only)
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	432
Number of Standardized 30-Day Fills	432
Aggregate Cost Paid for All Claims	2038.03
Number of Day's Supply for All Claims	2419
Number of Medicare Beneficiaries	179
Number of Claims, Including Refills, for Beneficiaries Age 65+	415
Including Refills, for Beneficiaries Age 65+	415
Beneficiaries Age 65+	1949.33
Number of Day's Supply for All Claims for Beneficaries Age 65+	2321
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	431
Aggregate Cost Paid for Generic Drugs	2034.39
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	94
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	321.66
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	338
Aggregate Cost Paid for Claims Filled by	1716.37
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	#
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	163
Aggregate Cost Paid for Opioid Drugs	434.55
Opioid Claims	136
Opioid_Tot_Clms divided by the Tot_Clms	37.731481481
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the	0
Total Claims of Antibiotic Drugs, Including	182
Aggregate Cost Paid for Antibiotic Drugs	723.99
Antibiotic Claims	146
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	72.932960894
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	110
Number of Male Beneficiaries	69
Number of Non-Hispanic White	160
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.0478288757